Koos van der Hoeven
Professor Internal Medicine, in particular the organisation of oncological care
- Name
- Prof.dr.ir. J.J.M. van der Hoeven
- Telephone
- +31 71 526 9111
- j.j.m.van.der.hoeven@lumc.nl
- ORCID iD
- 0000-0003-1117-1959
From 2012-2015 head of the department of Clinical Oncology at the Leiden University Medical Center. Since August 2015 full-time head of the department of Medical Oncology at the Radboud University Medical Center. I am still always professor at the LUMC in order to support 6 PhD students to their thesis
Organization of health care: oncology
Guiding 6 PhD students to their thesis.
Besides, focus on the organization of health care, especially for oncology
Academic career
1970-1975: Agricultural University Wageningen study Biology
1975- 1981: Vrije Universiteit Medical Center, Amsterdam study Medecine
1981-1986: trainee for medical oncologist at the Vrije Universiteit Medical center and Netherlands Cancer Institute
1986-1988: medical oncologist Vrije Universiteit Medical Center
1988-2007: medical oncologist Ziekenhuis Amstelland
2007-2012: medical oncologist medisch Centrum Alkmaar
Thesis 2004: Prospects for positron emission tomography in the staging and treatment of breast cancer patients
Oration LUMC 2013: Oncology towards 2020: prevention, collaboration and innovation
Oration Radboudumc 2017: Oncologie 3.0
Professor Internal Medicine, in particular the organisation of oncological care
- Faculteit Geneeskunde
- Divisie 4
- Klinische Oncologie
- Klinische Oncologie algemeen
- Groot, S. de; Gelderblom, H.; Fiocco, M.; Bovee, J.V.M.G.; Hoeven, J.J.M. van der; Pijl, H. & Kroep, J.R. (2017), Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy, OncoTargets and Therapy 10: 2963-2970.
- Jochems, A.; Schouwenburg, M.G.; Leeneman, B.; Franken, M.G.; Eertwegh, A.J.M. van den; Haanen, J.B.A.G.; Gelderblom, H.; Uyl-de Groot, C.A.; Aarts, M.J.B.; Berkmortel, F.W.P.J. van den; Blokx, W.A.M.; Cardous-Ubbink, M.C.; Groenewegen, G.; Groot, J.W.B. de; Hospers, G.A.P.; Kapiteijn, E.; Koornstra, R.H.; Kruit, W.H.; Louwman, M.W.; Piersma, D.; Rijn, R.S. van; Tije, A.J. ten; Vreugdenhil, G.; Wouters, M.W.J.M. & Hoeven, J.J.M. van der (2017), Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands, European Journal of Cancer 72: 156-165.
- Komen, M.; Smorenburg, C.; Nortier, H.; Ploeg, T. van der; Hurk, C. van den & Hoeven, K. van der (2016), Results of scalp cooling during chemotherapy with anthracyclines depend on scalp skin temperature, European Journal of Cancer 57: S29-S29.
- Charehbili, A.; Hamdy, N.A.T.; Smit, V.T.H.B.M.; Kessels, L.; Bochove, A. van; Laarhoven, H.W. van; Putter, H.; Kranenbarg, E.M.K.; Leeuwen-Stok, A.E. van; Hoeven, J.J.M. van der; Velde, C.J.H. van de; Nortier, J.W.R.; Kroep, J.R. & Dutch Breast Canc Res Grp BOOG (2016), Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01), Breast 25: 69-74.
- Komen, M.; Breed, W.; Smorenburg, C.; Ploeg, T. van der; Goey, S.H.; Hoeven, K. van der; Nortier, H. & Hurk, C. van den (2016), Results of 20 versus 45 minutes post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia, European Journal of Cancer 57: S29-S30.
- Morgans, A.K.; Bommel, A.C.M. van; Stowell, C.; Abrahm, J.L.; Basch, E.; Bekelman, J.E.; Berry, D.L.; Bossi, A.; Davis, I.D.; Reijke, T.M. de; Denis, L.J.; Evans, S.M.; Fleshner, N.E.; George, D.J.; Kiefert, J.; Lin, D.W.; Matthew, A.G.; McDermott, R.; Payne, H.; Roos, I.A.G.; Schrag, D.; Steuber, T.; Tombal, B.; Basten, J.P. van; Hoeven, J.J.M. van der; Penson, D.F. & Int Consortium Hlth Outcomes (2015), Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach, European Urology 68(5): 891-898.
- Groot, S. de; Janssen, L.G.M.; Charehbili, A.; Dijkgraaf, E.M.; Smit, V.T.H.B.M.; Kessels, L.W.; Bochove, A. van; Laarhoven, H.W.M. van; Kranenbarg, E.M.K.; Leeuwen-Stok, A.E. van; Velde, C.J.H. van de; Putter, H.; Nortier, J.W.R.; Hoeven, J.J.M. van der; Pijl, H. & Kroep, J.R. (2015), Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01), Breast Cancer Research and Treatment 149(2): 461-466.
- Hulle, T.V.D.; Exter, P.L. den; Hoven, P. van den; Hoeven, J.J. van der; Meer, F.J. van der; Eikenboom, J.; Huisman, M.V. & Klok, F.A. (2015), Safety of stopping anticoagulant treatment for cancer-associated venous thromboembolism after reaching complete remission from cancer, Journal of Thrombosis and Haemostasis 13: 987-987.
- Dijkgraaf, E.M.; Santegoets, S.J.A.M.; Reyners, A.K.L.; Goedemans, R.; Nijman, H.W.; Poelgeest, M.I.E. van; Erkel, A.R. van; Smit, V.T.H.B.M.; Daemen, T.A.H.H.; Hoeven, J.J.M. van der; Melief, C.J.M.; Welters, M.J.P.; Kroep, J.R. & Burg, S.H. van der (2015), A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer, Oncotarget 6(31): 32228-32243.
- Blok, E.J.; Derks, M.G.M.; Hoeven, J.J.M. van der; Velde, C.J.H. van de & Kroep, J.R. (2015), Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence, Cancer Treatment Reviews 41(3): 271-276.
- Groot, S. de; Vreeswijk, M.P.G.; Welters, M.J.P.; Gravesteijn, G.; Boei, J.J.W.A.; Jochems, A.; Houtsma, D.; Putter, H.; Hoeven, J.J.M. van der; Nortier, J.W.R.; Pijl, H. & Kroep, J.R. (2015), The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study, BMC Cancer 15.
- Dijkgraaf, E.M.; Santegoets, S.J.A.M.; Reyners, A.K.L.; Goedemans, R.; Wouters, M.C.A.; Kenter, G.G.; Erkel, A.R. van; Poelgeest, M.I.E. van; Nijman, H.W.; Hoeven, J.J.M. van der; Welters, M.J.P.; Burg, S.H. van der & Kroep, J.R. (2015), A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-alpha 2b in patients with recurrent epithelial ovarian cancer, Annals of Oncology 26(10): 2141-2149.
- Morgans, A.K.; Bommel, A.C.M. van; Stowell, C.; Abrahm, J.L.; Basch, E.; Bekelman, J.E.; Berry, D.L.; Bossi, A.; Davis, I.D.; Reijke, T.M. de; Denis, L.J.; Evans, S.M.; Fleshner, N.E.; George, D.J.; Kiefert, J.; Lin, D.W.; Matthew, A.G.; McDermott, R.; Payne, H.; Roos, I.A.G.; Schrag, D.; Steuber, T.; Tombal, B.; Basten, J. van; Hoeven, J.J.M. van der & Penson, D. (2015), DEVELOPMENT OF A STANDARDIZED SET OF PATIENT-CENTERED OUTCOMES FOR ADVANCED PROSTATE CANCER: AN INTERNATIONAL EFFORT FOR A UNIFIED APPROACH, Asia-Pacific Journal of Clinical Oncology 11: 29-29.
- Schneider, T.C.; Wit, D. de; Links, T.P.; Erp, N.P. van; Hoeven, J.J.M. van der; Gelderblom, H.; Wezel, T. van; Eijk, R. van; Morreau, H.; Guchelaar, H.J. & Kapiteijn, E. (2015), Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial, International Journal of Endocrinology.
- Groot, S. de; Charehbili, A.; Janssen, L.G.M.; Dijkgraaf, E.M.; Smit, V.T.H.B.M.; Kessels, L.W.; Bochove, A. van; Laarhoven, H.W.M. van; Kranenbarg, E.M.K.; Leeuwen-Stok, A.E. van; Liefers, G.J.; Velde, C.J.H. van de; Nortier, J.W.R.; Hoeven, J.J.M. van der; Pijl, H. & Kroep, J.R. (2015), Thyroid function is associated with the response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial on behalf of the Dutch Breast Cancer Research Group (BOOG 2010-01), Cancer Research 75(9).
- Kaptein, A.A.; Schoones, J.W.; Fischer, M.J.; Thong, M.S.Y.; Kroep, J.R. & Hoeven, K.J.M. van der (2015), Illness perceptions in women with breast cancer-a systematic literature review, Current Breast Cancer Reports 7(3).
- Siesling, S.; Tjan-Heijnen, V.C.G.; Roos, M. de; Snel, Y.; Dalen, T. van; Wouters, M.W.; Struikmans, H.; Hoeven, J.J.M. van der; Maduro, J.H. & Visser, O. (2014), Impact of hospital volume on breast cancer outcome: a population-based study in the Netherlands, Breast Cancer Research and Treatment 147(1): 177-184.
- Wouters, M.C.A.; Dijkgraaf, E.M.; Kuijjer, M.L.; Jordanova, E.S.; Hollema, H.; Welters, M.J.P.; Hoeven, J.J.M. van der; Daemen, T.; Kroep, J.R.; Nijman, H.W. & Burg, S. van der (2014), Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer.
- Hulle, T. van der; Exter, P.L. den; Kooiman, J.; Hoeven, J.J.M. van der; Huisman, M.V. & Klok, F.A. (2014), Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism, Journal of Thrombosis and Haemostasis 12(7): 1116-1120.
- Engelhardt, E.G.; Garvelink, M.M.; Haes, J.C.J.M. de; Hoeven, J.J.M. van der; Smets, E.M.A.; Pieterse, A.H. & Stiggelbout, A.M. (2014), Predicting and Communicating the Risk of Recurrence and Death in Women With Early-Stage Breast Cancer: A Systematic Review of Risk Prediction Models, Journal of Clinical Oncology 32(3): 238-+.
- Dekker, T.J.A.; Velde, C.J.H. van de; Bruggen, D. van; Mesker, W.E.; Hoeven, J.J.M. van der; Kroep, J.R.; Tollenaar, R.A.E.M. & Smit, V.T.H.B.M. (2013), Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer, Annals of Oncology 24(12): 2994-2998.
- Dekker, T.J.A.; Velde, C.J.H. van de; Bruggen, D. van; Mesker, W.E.; Hoeven, J.J.M. van der; Tollenaar, R.A.E.M.; Kroep, J.R. & Smit, V. (2013), Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer patients, European Journal of Cancer 49: S210-S210.
- Siesling, S.; Tjan-Heijnen, V.C.G.; Roos, M. de; Snel, Y.E.M.; Dalen, T. van; Wouters, M.W.; Struikmans, H.; Maduro, J.H.; Hoeven, J.J.M. van der & Visser, O. (2013), Impact of hospital surgical volume on breast cancer outcome: A population based study in the Netherlands, European Journal of Cancer 49: S430-S431.
- Lubberink, M.; Direcks, W.; Emmering, J.; Tinteren, H. van; Hoekstra, O.S.; Hoeven, J.J. van der; Molthoff, C.F.M. & Lammertsma, A.A. (2012), Validity of Simplified 3 '-Deoxy-3 '-[F-18]Fluorothymidine Uptake Measures for Monitoring Response to Chemotherapy in Locally Advanced Breast Cancer, Molecular Imaging and Biology 14(6): 777-782.
- Bestuurslid
- Voorzitter
- Lid Adviesraad
- Redacteur
- Incidenteel lid adviesraad